Infectious complications after transrectal MRI-targeted and systematic prostate biopsy - Takeaways - MDSpire

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy

  • By

  • Inari Kalalahti

  • Kaisa Huotari

  • Andrew. M. Erickson

  • Anssi Petas

  • Hanna Vasarainen

  • Antti Rannikko

  • August 5, 2022

  • 0 min

Share

  • 1

    Prostate biopsy is essential for diagnosing prostate cancer but carries risks of complications, primarily infections.

  • 2

    Infections after transrectal biopsy occur in 0.1 to 7.0% of cases, with rising hospitalization rates due to these infections.

  • 3

    MRI-targeted biopsy significantly reduces the incidence of infections compared to systematic biopsy.

  • 4

    In this study, MRI-targeted biopsy showed lower rates of positive urine cultures and elevated CRP levels than systematic biopsy.

  • 5

    Despite no significant difference in blood culture positive infections, other infectious complications were more common after systematic biopsy.

Original Source(s)

Related Content